Craig-Hallum analyst Bill Bonello lowered the firm’s price target on Exact Sciences (EXAS) to $65 from $82 and keeps a Buy rating on the shares. The firm expect shares to be down substantially as the company reported a modest Q3 revenue miss and significantly lowered full year guidance. While Craig-Hallum expects the shares to recover over time, it thinks it will take a few quarters for management to regain investor confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences price target raised to $85 from $84 at Jefferies
- Exact Sciences price target lowered to $60 from $80 at Evercore ISI
- Exact Sciences weakness after guidedown a buying opportunity, says Benchmark
- Exact Sciences price target lowered to $67 from $82 at Stifel
- Exact Sciences price target lowered to $65 from $82 at BTIG